Stereotactic Body Radiation Therapy Reirradiation for Locally Recurrent Rectal Cancer: Outcomes and Toxicity | Zendy

Thomas J. Smith | Zendy; Séan M. O’Cathail | Zendy; S. Silverman | Zendy; M. Robinson | Zendy; Y. Tsang | Zendy; Mark Harrison | Zendy; M. Hawkins | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Stereotactic Body Radiation Therapy Reirradiation for Locally Recurrent Rectal Cancer: Outcomes and Toxicity

Author(s) -

Thomas J. Smith,

Séan M. O’Cathail,

S. Silverman,

M. Robinson,

Y. Tsang,

Mark Harrison,

M. Hawkins

Publication year - 2020

Publication title -

advances in radiation oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.989

H-Index - 19

ISSN - 2452-1094

DOI - 10.1016/j.adro.2020.07.017

Subject(s) - medicine , interquartile range , radiation therapy , colorectal cancer , confidence interval , dose fractionation , prospective cohort study , cohort , hazard ratio , radiosurgery , surgery , cancer

Stereotactic body radiation therapy (SBRT) has emerged as a potential therapeutic option for locally recurrent rectal cancer (LRRC) but contemporaneous clinical data are limited. We aimed to evaluate the local control, toxicity, and survival outcomes in a cohort of patients previously treated with neoadjuvant pelvic radiation therapy for nonmetastatic locally recurrent rectal cancer, now treated with SBRT.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research